For children, young adults with recurrent AML, immunotherapy shows promise
Researchers at Washington University School of Medicine have shown, in a small clinical trial, that pre-activated natural killer cells can help some children and young adults with recurrent acute myeloid leukemia and few other treatment options.
Asthma may reduce risk of brain tumors — but how?
Asthma has been associated with a lowered risk of brain tumors, and researchers at Washington University School of Medicine now think they know why: Immune cells activated under conditions of asthma are less able to promote the growth of brain tumors.
Covey, Milbrandt, Moran named to National Academy of Inventors
Washington University in St. Louis faculty from the School of Medicine and the McKelvey School of Engineering have been elected fellows of the National Academy of Inventors, the highest professional distinction reserved solely for academic inventors.
Antipsychotic drugs may increase risk of breast cancer
Researchers at Washington University School of Medicine have found that many commonly prescribed antipsychotic medications are associated with a significant increase in risk of breast cancer.
Mapping the brain
Our brains make maps to help navigate the world. In her latest book, Rebecca Schwarzlose examines how these maps shape our world.
Impacting millions
His work in pharmaceuticals has brought drugs to market that have saved countless lives, and Frank Jiang is just getting started.
U.S. drug prices are costing us more than we think
Aduhelm, the first new Alzheimer’s drug in 18 years, could easily become the best-selling drug in Medicare, despite its potential massive cost and tremendous uncertainty about whether the drug even works.
Explaining Cancer
Finding Order in Disorder
Cancer is the second leading cause of death in the world. Almost everyone’s life is in some way or other affected by cancer. Yet, when faced with a cancer diagnosis, many of us will confront questions we had never before considered: Is cancer one disease, or many?
Research sheds light on rotator cuff injuries
A team of researchers co-led by Guy Genin at the McKelvey School of Engineering has made a discovery about how tendon and bone attach in the shoulder joint, shedding light on rotator cuff injuries and how to treat them.
Drug compound makes pancreatic cancer cells more vulnerable to chemo
Researchers at Washington University School of Medicine have identified a drug compound that makes pancreatic cancer cells more vulnerable to chemotherapy.
Older Stories